What is Spark Biomedical?
Spark Biomedical is pioneering wearable neurostimulation for opioid withdrawal, mental health, and women’s health. Its FDA-cleared Sparrow® device delivers symptom relief within one hour for 80%+ of users—and its next innovation, OhmBody, targets menstrual pain, fatigue, and endometriosis through non-hormonal, wearable therapy. With 59M U.S. women affected monthly and an $80B+ addressable market, Spark is positioned to lead the next generation of drug-free neuromodulation solutions.
“Neurostimulation: A Better Way Forward. We provide the world with drug-free treatment options through innovative, non-invasive, wearable neurostimulation technology.”
Competitive Advantages:
FDA-cleared Sparrow® device - clinically proven, revenue-generating foundation.
OhmBody platform expansion into women’s health multiplies addressable market.
Non-hormonal, wearable therapy appeals to modern health and wellness consumers.
Strong IP moat and clinical validation support medical and consumer credibility.
Redemptive tech story - helping people overcome pain and addiction through innovation.
HKR WhiteFlag Theme Verse
“But he said to me, “My grace is sufficient for you, for my power is made perfect in weakness.” Therefore I will boast all the more gladly about my weaknesses, so that Christ’s power may rest on me.”